WELLINGTON MANAGEMENT GROUP LLP - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 58 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2014$82,000
+9.3%
16,6310.0%0.00%
Q2 2014$75,000
-39.5%
16,631
-39.8%
0.00%
Q1 2014$124,000
-12.1%
27,6110.0%0.00%
Q4 2013$141,000
+12.8%
27,6110.0%0.00%
Q3 2013$125,000
-11.3%
27,6110.0%0.00%
Q2 2013$141,00027,6110.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,218,401$6,957,0004.07%
BARD ASSOCIATES INC 395,575$2,260,0000.21%
Ariel Investments 1,290,317$7,368,0000.08%
Ballew Advisors, Inc 5,557$31,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,400$1,173,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$68,0000.01%
Oakworth Capital, Inc. 3,052$17,0000.00%
Spark Investment Management LLC 10,800$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 878,348$5,015,0000.00%
Renaissance Technologies 381,471$2,178,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders